Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03670264 · ClinicalTrials.gov registry record · NA
BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation
A NA study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03670264: Clinical Trial NA study, sponsored by Children's Hospital of Philadelphia.
NCT03670264 is a NA study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03670264, a NA study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
More than 90% of adult smokers initiate tobacco use before age 18, making prevention and treatment of adolescent smoking a critical health priority. Behavioral economic interventions utilizing financial incentives can promote smoking cessation in adult populations. No studies have evaluated financial incentives among adolescents to promote engagement in effective tobacco cessation programs through primary care settings. The goal of this study is to to compare, through a pilot, randomized controlled trial, an intervention incentivizing contact with a tobacco cessation program (the Quitline), an intervention incentivizing quitting, or no financial incentive intervention on adolescent smoker enrollment and depth of engagement in the tobacco cessation program.
Primary Outcome
Adolescent completion of the tobacco cessation program, defined as the proportion of tobacco users identified in the clinic that enroll, use, and complete the Quitline program compared across the 3 groups
Interventions
- BEHAVIORAL Quitline Delivered Treatment
- BEHAVIORAL Quitline Incentive
- BEHAVIORAL Tobacco Cessation Incentive
- BEHAVIORAL Way to Health (WTH) Platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-09-21 |
| Est. Completion | 2021-03-19 |
| Phase | NA |
Why NCT03670264 stopped before completion
NCT03670264 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Quitline Delivered Treatment is the first listed.
NCT03670264 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03670264 about?
NCT03670264 is a clinical study titled "BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation". More than 90% of adult smokers initiate tobacco use before age 18, making prevention and treatment of adolescent smoking a critical health priority. Behavioral economic interventions utilizing financial incentives can promote smoking cessation in adult populations. No studies have evaluated financia...
What is the current status of trial NCT03670264?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2018-09-21. Estimated completion is 2021-03-19.
What interventions are being tested in trial NCT03670264?
The interventions under investigation include: Quitline Delivered Treatment (BEHAVIORAL), Quitline Incentive (BEHAVIORAL), Tobacco Cessation Incentive (BEHAVIORAL), Way to Health (WTH) Platform (BEHAVIORAL).
Who is sponsoring clinical trial NCT03670264?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03670264's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI